A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitro

Author:

Huang Grace L.,Nampe Daniel P.,Yi Jason,Gabrelow Grant B.,Negri Kathleen R.,Kamb Alexander,Xu HanORCID

Abstract

Cell therapy is poised to play a larger role in medicine, most notably for immuno-oncology. Despite the recent success of CAR-T therapeutics in the treatment of blood tumors and the rapid progress toward improved versions of both CAR- and TCR-Ts, important analytical aspects of preclinical development and manufacturing of engineered T cells remain immature. One limiting factor is the absence of robust multivariate assays to disentangle key parameters related to function of engineered effector cells, especially in the peptide-MHC (pMHC) target realm, the natural ligand for TCRs. Here we describe an imaging-based primary T cell assay that addresses several of these limitations. To our knowledge, this assay is the first quantitative, high-content assay that separates the key functional parameters of time- and antigen-dependent T cell proliferation from cytotoxicity. We show that the assay sheds light on relevant biology of CAR- and TCR-T cells, including response kinetics and the influence of effector:target ratio.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. A guide to manufacturing CAR T cell therapies;P Vormittag;Curr Opin Biotechnol,2018

2. Designing chimeric antigen receptors to effectively and safely target tumors;MC Jensen;Curr Opin Immunol,2015

3. Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma;FL Locke;Mol Ther,2017

4. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;SJ Schuster;N Engl J Med,2019

5. Management of ‘out of specification’ commercial autologous CAR-T cell products;A Bersenev;Cell Gene Ther Insights,2018

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3